Oscar Health, Inc. reports results for the quarter ended September 30 - Earnings Summary

• Oscar Health, Inc. OSCR.N reported quarterly adjusted earnings of 49 cents​​ per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of -53 cents. The mean expectation of twelve analysts for the quarter was for a loss of 21 cents per share. Wall Street expected results to range from -53 cents to 7 cents per share.

• Revenue rose 72.1% to $5.14 billion from a year ago; analysts expected $4.72 billion.

• Oscar Health, Inc.'s reported EPS for the quarter was 49 cents​.

• The company reported quarterly net income of $167.28 million.

• Oscar Health, Inc. shares had risen by 14.1% this quarter and gained 144.9% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 4.8% in the last three months.​

• In the last 30 days, one analyst negatively revised an earnings estimate

RECOMMENDATIONS

• The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 5 "strong buy" or "buy," 7 "hold" and 1 "sell" or "strong sell." The average consensus recommendation for the life & health insurance peer group is "buy."

• Wall Street's median 12-month price target for Oscar Health, Inc. is $34.00, about 3.5% below its last closing price of $35.19

This summary was machine generated from LSEG data November 5 at 02:31 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)